Keith H. Loven

860 total citations
11 papers, 650 citations indexed

About

Keith H. Loven is a scholar working on Dermatology, Epidemiology and Infectious Diseases. According to data from OpenAlex, Keith H. Loven has authored 11 papers receiving a total of 650 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Dermatology, 4 papers in Epidemiology and 2 papers in Infectious Diseases. Recurrent topics in Keith H. Loven's work include Acne and Rosacea Treatments and Effects (5 papers), Skin Protection and Aging (3 papers) and Dermatology and Skin Diseases (3 papers). Keith H. Loven is often cited by papers focused on Acne and Rosacea Treatments and Effects (5 papers), Skin Protection and Aging (3 papers) and Dermatology and Skin Diseases (3 papers). Keith H. Loven collaborates with scholars based in United States, Canada and France. Keith H. Loven's co-authors include Charles N. Ellis, Dow B. Stough, Gerald G. Krueger, Wayne Gulliver, Kim Papp, Sharon Levy, Linda Stein, Katharine Furst, Barry A. Solomon and David A. Whiting and has published in prestigious journals such as Journal of the American Academy of Dermatology, British Journal of Dermatology and Clinical Therapeutics.

In The Last Decade

Keith H. Loven

11 papers receiving 601 citations

Peers

Keith H. Loven
Keith H. Loven
Citations per year, relative to Keith H. Loven Keith H. Loven (= 1×) peers Sara Mazzilli

Countries citing papers authored by Keith H. Loven

Since Specialization
Citations

This map shows the geographic impact of Keith H. Loven's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keith H. Loven with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keith H. Loven more than expected).

Fields of papers citing papers by Keith H. Loven

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Keith H. Loven. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keith H. Loven. The network helps show where Keith H. Loven may publish in the future.

Co-authorship network of co-authors of Keith H. Loven

This figure shows the co-authorship network connecting the top 25 collaborators of Keith H. Loven. A scholar is included among the top collaborators of Keith H. Loven based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Keith H. Loven. Keith H. Loven is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Lee, Peter K., Keith H. Loven, Tania J. Phillips, et al.. (2006). Long-Term Clinical Outcomes Following Treatment of Actinic Keratosis with Imiquimod 5% Cream. Dermatologic Surgery. 31(6). 659–664. 34 indexed citations
2.
Tanghetti, Emil, William Abramovits, Barry A. Solomon, Keith H. Loven, & Alan R. Shalita. (2005). Tazarotene versus tazarotene plus clindamycin/benzoyl peroxide in the treatment of acne vulgaris: A multicenter, double-blind, randomized, parallel-group trial. Journal of the American Academy of Dermatology. 52(3). P22–P22. 24 indexed citations
3.
Shalita, Alan R., et al.. (2005). Tazarotene cream versus adapalene cream in the treatment of facial acne vulgaris: a multicenter, double-blind, randomized, parallel-group study.. PubMed. 4(2). 153–8. 19 indexed citations
4.
Lee, Peter K., Keith H. Loven, Tania J. Phillips, et al.. (2005). Long-Term Clinical Outcomes Following Treatment of Actinic Keratosis with Imiquimod 5% Cream. Dermatologic Surgery. 31(6). 659–663. 28 indexed citations
6.
Wolf, John E., David L. Kaplan, Stephen J. Kraus, et al.. (2003). Efficacy and tolerability of combined topical treatment of acne vulgaris with adapalene and clindamycin: a multicenter, randomized, investigator-blinded study. Journal of the American Academy of Dermatology. 49(3). S211–S217. 77 indexed citations
7.
Webster, Guy, Lyn Guenther, Yves Poulin, et al.. (2002). A multicenter, double-blind, randomized comparison study of the efficacy and tolerability of once-daily tazarotene 0.1% gel and adapalene 0.1% gel for the treatment of facial acne vulgaris.. PubMed. 69(2 Suppl). 4–11. 39 indexed citations
8.
Krueger, Gerald G., Kim Papp, Dow B. Stough, et al.. (2002). A randomized, double-blind, placebo-controlled phase III study evaluating efficacy and tolerability of 2 courses of alefacept in patients with chronic plaque psoriasis. Journal of the American Academy of Dermatology. 47(6). 821–833. 262 indexed citations
9.
Loven, Keith H., Linda Stein, Katharine Furst, & Sharon Levy. (2002). Evaluation of the efficacy and tolerability of 0.5% fluorouracil cream and 5% fluorouracil cream applied to each side of the face in patients with actinic keratosis. Clinical Therapeutics. 24(6). 990–1000. 127 indexed citations
10.
Rich, Peter, Anthony LaMarca, Keith H. Loven, et al.. (2001). Safety and efficacy of short-duration oral terbinafine for the treatment of tinea corporis or tinea cruris in subjects with HIV infection or diabetes.. PubMed. 68(1 Suppl). 15–22. 4 indexed citations
11.
Lucky, Anne W., Joseph L. Jorizzo, Terence M. Jones, et al.. (2001). Efficacy and tolerance of adapalene cream 0.1% compared with its cream vehicle for the treatment of acne vulgaris.. PubMed. 68(4 Suppl). 34–40. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026